CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C06504 | BRD-K13113551 | BRD-K13113551 | -- | -- | -- | Details |
C06505 | BRD-K13118417 | BRD-K13118417 | -- | -- | -- | Details |
C06506 | BRD-K13118793 | BRD-K13118793 | -- | -- | -- | Details |
C06507 | BRD-K13119088 | BRD-K13119088 | -- | -- | -- | Details |
C06508 | BRD-K13119652 | BRD-K13119652 | -- | -- | -- | Details |
C06509 | BRD-K13122423 | BRD-K13122423 | -- | -- | -- | Details |
C06510 | BRD-K13122526 | BRD-K13122526 | -- | -- | -- | Details |
C06511 | BRD-K13130949 | BRD-K13130949 | -- | -- | -- | Details |
C06512 | BRD-K13131627 | BRD-K13131627 | -- | -- | -- | Details |
C06513 | BRD-K13137954 | BRD-K13137954 | -- | -- | -- | Details |
C06514 | BRD-K13141487 | BRD-K13141487 | -- | -- | -- | Details |
C06515 | BRD-K13146765 | BRD-K13146765 | -- | -- | -- | Details |
C06516 | BRD-K13146924 | BRD-K13146924 | -- | -- | -- | Details |
C06517 | BRD-K13150695 | BRD-K13150695 | -- | -- | -- | Details |
C06518 | BRD-K13154216 | everolimus | MTOR | MTOR inhibitor | -- | Details |
C06519 | BRD-K13164804 | BRD-K13164804 | -- | -- | -- | Details |
C06520 | BRD-K13166308 | BRD-K13166308 | -- | -- | -- | Details |
C06521 | BRD-K13169950 | NSC-3852 | HDAC1 | HDAC inhibitor | -- | Details |
C06522 | BRD-K13175698 | BRD-K13175698 | -- | -- | -- | Details |
C06523 | BRD-K13183738 | pentamidine | -- | -- | -- | Details |
C06524 | BRD-K13183999 | BRD-K13183999 | -- | -- | -- | Details |
C06525 | BRD-K13185470 | DFCI-LW10 | -- | -- | -- | Details |
C06526 | BRD-K13185593 | BRD-K13185593 | -- | -- | -- | Details |
C06527 | BRD-K13190592 | BRD-K13190592 | -- | -- | -- | Details |
C06528 | BRD-K13190943 | BRD-K13190943 | -- | -- | -- | Details |
C06529 | BRD-K13195996 | BRD-K13195996 | -- | -- | -- | Details |
C06530 | BRD-K13196166 | BRD-K13196166 | -- | -- | -- | Details |
C06531 | BRD-K13199470 | BRD-K13199470 | -- | -- | -- | Details |
C06532 | BRD-K13204142 | BRD-K13204142 | -- | -- | -- | Details |
C06533 | BRD-K13205342 | BRD-K13205342 | -- | -- | -- | Details |
C06534 | BRD-K13206026 | BRD-K13206026 | -- | -- | -- | Details |
C06535 | BRD-K13207999 | BRD-K13207999 | -- | -- | -- | Details |
C06536 | BRD-K13211285 | BRD-K13211285 | -- | -- | -- | Details |
C06537 | BRD-K13211965 | L-741742 | DRD4 | Dopamine receptor antagonist | -- | Details |
C06538 | BRD-K13217265 | BRD-K13217265 | -- | -- | -- | Details |
C06539 | BRD-K13218245 | BRD-K13218245 | -- | -- | -- | Details |
C06540 | BRD-K13225050 | BRD-K13225050 | -- | -- | -- | Details |
C06541 | BRD-K13226037 | BRD-K13226037 | -- | -- | -- | Details |
C06542 | BRD-K13226207 | BRD-K13226207 | -- | -- | -- | Details |
C06543 | BRD-K13229082 | BRD-K13229082 | -- | -- | -- | Details |
C06544 | BRD-K13234528 | BRD-K13234528 | -- | -- | -- | Details |
C06545 | BRD-K13235291 | BRD-K13235291 | -- | -- | -- | Details |
C06546 | BRD-K13238168 | haloprogin | -- | -- | -- | Details |
C06547 | BRD-K13240564 | crotamiton | -- | -- | -- | Details |
C06548 | BRD-K13241788 | BRD-K13241788 | -- | -- | -- | Details |
C06549 | BRD-K13245569 | BRD-K13245569 | -- | -- | -- | Details |
C06550 | BRD-K13249881 | piperazine | -- | -- | -- | Details |
C06551 | BRD-K13257316 | BRD-K13257316 | -- | -- | -- | Details |
C06552 | BRD-K13261168 | LY-16350 | -- | -- | quinelorane | Details |
C06553 | BRD-K13265046 | BRD-K13265046 | -- | -- | -- | Details |
C06554 | BRD-K13267130 | BRD-K13267130 | -- | -- | -- | Details |
C06555 | BRD-K13267677 | BRD-K13267677 | -- | -- | -- | Details |
C06556 | BRD-K13271778 | BRD-K13271778 | -- | -- | -- | Details |
C06557 | BRD-K13272610 | BRD-K13272610 | -- | -- | -- | Details |
C06558 | BRD-K13274297 | BRD-K13274297 | -- | -- | -- | Details |
C06559 | BRD-K13275816 | BRD-K13275816 | -- | -- | -- | Details |
C06560 | BRD-K13275849 | BRD-K13275849 | -- | -- | -- | Details |
C06561 | BRD-K13277629 | BRD-K13277629 | -- | -- | -- | Details |
C06562 | BRD-K13279882 | BRD-K13279882 | -- | -- | -- | Details |
C06563 | BRD-K13289658 | BRD-K13289658 | -- | -- | -- | Details |
C06564 | BRD-K13296708 | rimonabant | CNR1 | Cannabinoid receptor antagonist | -- | Details |
C06565 | BRD-K13299110 | BRD-K13299110 | -- | -- | -- | Details |
C06566 | BRD-K13299591 | BRD-K13299591 | -- | -- | -- | Details |
C06567 | BRD-K13299646 | BRD-K13299646 | -- | -- | -- | Details |
C06568 | BRD-K13301506 | BRD-K13301506 | -- | -- | -- | Details |
C06569 | BRD-K13304927 | BRD-K13304927 | -- | -- | -- | Details |
C06570 | BRD-K13306582 | SA-424534 | -- | -- | -- | Details |
C06571 | BRD-K13307254 | BRD-K13307254 | -- | -- | -- | Details |
C06572 | BRD-K13308287 | BRD-K13308287 | -- | -- | -- | Details |
C06573 | BRD-K13309366 | BRD-K13309366 | -- | -- | -- | Details |
C06574 | BRD-K13309514 | BRD-K13309514 | -- | -- | -- | Details |
C06575 | BRD-K13317726 | BRD-K13317726 | -- | -- | -- | Details |
C06576 | BRD-K13318664 | BRD-K13318664 | -- | -- | -- | Details |
C06577 | BRD-K13320013 | BRD-K13320013 | -- | -- | -- | Details |
C06578 | BRD-K13324372 | BRD-K13324372 | -- | -- | -- | Details |
C06579 | BRD-K13330525 | BRD-K13330525 | -- | -- | -- | Details |
C06580 | BRD-K13336710 | BRD-K13336710 | -- | -- | -- | Details |
C06581 | BRD-K13346599 | BRD-K13346599 | -- | -- | -- | Details |
C06582 | BRD-K13350372 | BRD-K13350372 | -- | -- | -- | Details |
C06583 | BRD-K13352537 | BRD-K13352537 | -- | -- | -- | Details |
C06584 | BRD-K13356952 | methazolamide | CA1; CA2; CA4; CA7 | Carbonic anhydrase inhibitor | -- | Details |
C06585 | BRD-K13365737 | BRD-K13365737 | -- | -- | -- | Details |
C06586 | BRD-K13369161 | BRD-K13369161 | -- | -- | -- | Details |
C06587 | BRD-K13370005 | BRD-K13370005 | -- | -- | -- | Details |
C06588 | BRD-K13383838 | BRD-K13383838 | -- | -- | -- | Details |
C06589 | BRD-K13387373 | thonzonium | -- | -- | -- | Details |
C06590 | BRD-K13389917 | BRD-K13389917 | -- | -- | -- | Details |
C06591 | BRD-K13390322 | AT-7519 | CDK2; CDK4; CDK5; CDK6; CDK9; CDK1 | CDK inhibitor; Cell cycle inhibitor | -- | Details |
C06592 | BRD-K13397460 | BRD-K13397460 | -- | -- | -- | Details |
C06593 | BRD-K13400061 | BRD-K13400061 | -- | -- | -- | Details |
C06594 | BRD-K13401825 | BRD-K13401825 | -- | -- | -- | Details |
C06595 | BRD-K13402127 | BRD-K13402127 | -- | -- | -- | Details |
C06596 | BRD-K13411423 | BRD-K13411423 | -- | -- | -- | Details |
C06597 | BRD-K13411622 | SA-441487 | -- | -- | -- | Details |
C06598 | BRD-K13417398 | BRD-K13417398 | -- | -- | -- | Details |
C06599 | BRD-K13418716 | BRD-K13418716 | -- | -- | -- | Details |
C06600 | BRD-K13425292 | BRD-K13425292 | -- | -- | -- | Details |
C06601 | BRD-K13428252 | BRD-K13428252 | -- | -- | -- | Details |
C06602 | BRD-K13436682 | BRD-K13436682 | -- | -- | -- | Details |
C06603 | BRD-K13445266 | BRD-K13445266 | -- | -- | -- | Details |